The Brazilian Controlled Drugs and Substances Act (Portuguese: Regulamento Técnico sobre substâncias e medicamentos sujeitos a controle especial), officially Portaria nº 344/1998,[1] is Brazil's federal drug control statute, issued by the Ministry of Health through its National Health Surveillance Agency (Anvisa). The act also serves as the implementing legislation for the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances in the country.
The list was last updated in May 2024.[2]
Terminology:
- Prescription notification - a standardized document intended for notifying Anvisa of the prescription of medications. Written by the doctor and retained by the drugstore
- Prescription - a written medication order that provides usage instructions for the patient.
- Special control prescription - a prescrition that is filled out in two copies, one that is retained by the drugstore, and another stays with the patient for usage guidance. It can be provided in a digital signed form.[3]
- ^ Anvisa. "Portaria nº 344, de 12 de maio de 1998 com atualizações" [Ordinance No. 344 of May 12, 1998 with amendments] (in Brazilian Portuguese). Retrieved 2024-10-03.
- ^ Anvisa (2024-05-28). "RDC Nº 877 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 877 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União. Archived from the original on 2024-09-25. Retrieved 2024-09-25.
- ^ Rodrigo, Kleber (2020-03-26). "Medicamentos controlados: receitas com assinatura digital". Abcfarma (in Brazilian Portuguese). Archived from the original on 2023-08-16. Retrieved 2023-08-16.